HARRY WEISMAN, M.D

M.D

Endocrinology, Diabetes & Metabolism Physician

NPI: 1063443349Individual

Specialties, Licenses & Credentials

Endocrinology, Diabetes & Metabolism PhysicianPrimary

Internal Medicine — Endocrinology, Diabetes & Metabolism

Code: 207RE0101X

G29245(CA)

Research & Publications (3)

Antagonism of E2F-1 regulated Bnip3 transcription by NF-kappaB is essential for basal cell survival.

PMID 19088195·Proc Natl Acad Sci U S A·2008

7-preclinical

Long-term mortality benefit with abciximab in patients undergoing percutaneous coronary intervention.

PMID 11419888·J Am Coll Cardiol·2001

8-other

Therapeutic heparin concentrations augment platelet reactivity: implications for the pharmacologic assessment of the glycoprotein IIb/IIIa antagonist abciximab.

PMID 10740154·Am Heart J·2000

8-other

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Request Appointment

Contact & Hours

Address: 100 UCLA MEDICAL PLZ, SUITE 220
LOS ANGELES, CA 90024
Phone: (310) 794-9666

Quick Facts

NPI: 1063443349
Entity Type: Individual
Gender: Male
Medicare: Not confirmed
Specialties: 1
Locations: 1
Publications: 3

Are you this provider?

Claim Your Profile